申请人:Virochem Pharma Inc.
公开号:EP2546246A2
公开(公告)日:2013-01-16
Compounds represented by formula I:
or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, Y1, and Z are as defined herein, are useful for treating flaviviridae viral infections.
式 I 所代表的化合物:
或其药学上可接受的盐和溶液,其中 R1、X、Y、Y1 和 Z 如本文所定义,可用于治疗黄病毒科病毒感染。